Iponews studio: Zhiyun Health officially landed on the Hong Kong Stock Exchange with a market value of more than HK$17.3 billion

Published on July 6, 2022

Zhiyun Health, a startup created by Ming Kuang, alumnus of Cambridge Judge Business School (MBA 2010) was officially listed on the Main Board of the Hong Kong Stock Exchange today, with Morgan Stanley and JPMorgan Chase & Co. as joint sponsors, becoming the “first stock of chronic disease management” in Hong Kong stocks with a market value of more than HK$17.3 billion, the article says. (transl. from Chinese)

Read the full article [mp.weixin.qq.com]

The post Iponews studio: Zhiyun Health officially landed on the Hong Kong Stock Exchange with a market value of more than HK$17.3 billion appeared first on Cambridge Judge Business School.

Continue reading on website
Other news

Novel all-in-one vaccine developed to tackle future coronavirus threats

July 6, 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

Oxford researchers become EMBO members

July 6, 2022
Three University of Oxford academics have become the latest to join the 1,900 eminent life scientists in Europe and beyond that make up the European Molecular Biology Organization (EMBO).